Inverse relationship of peripheral thyrotropin-stimulating hormone levels to brain activity in mood disorders

American Journal of Psychiatry

Volumn 154, Issue 2, 1997, Pages 224-230

  Marangell, Lauren B ^a   Ketter, Terence A ^a   George, Mark S ^a   Pazzaglia, Peggy J ^a   Callahan, Ann M ^a   Parekh, Priti ^a   Andreason, Paul J ^a   Horwitz, Barry ^a   Herscovitch, Peter ^a   Post, Robert M ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; LIOTHYRONINE; OXYGEN 15; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; BRAIN BLOOD FLOW; BRAIN CIRCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; FREE THYROXINE INDEX; GLUCOSE METABOLISM; HUMAN; MALE; MANIC DEPRESSIVE PSYCHOSIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; THYROID HORMONE BLOOD LEVEL; THYROTROPIN BLOOD LEVEL;

EID: 0031018536     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.154.2.224     Document Type: Article

References (52)

1. Kirkegaard C, Faber J: Altered serum levels of thyroxine, triiodothyronines and diiodothyronines in endogenous depression. Acta Endocrinol (Copenh) 1981; 96:199-207
2. Joffe RT, Roy-Byrne PP, Uhde TW, Post RM: Thyroid function and affective illness: a reappraisal. Biol Psychiatry 1984; 19:1685-1691
3. Bauer MS, Whybrow PC: Thyroid hormones and the central nervous system in affective illness: interactions that may have clinical significance. Integrative Psychiatry 1988; 6:75-100
4. Prange AJ Jr, Loosen PT, Wilson IC, Lipton MA: The therapeutic use of hormones of the thyroid axis in depression, in Neurobiology of Mood Disorders. Edited by Post RM, Ballenger JC. Baltimore, Williams & Wilkins, 1984, pp 311-322
5. Whybrow PC, Bauer MS, Gyulai L: Thyroid axis considerations in patients with rapid cycling affective disorder. Clin Neuropharmacol 1992; 15(suppl 1, part A):391A-392A
6. Kirkegaard C, Faber J: Free thyroxine and 3,3′,5-triiodothyronine levels in cerebrospinal fluid in patients with endogenous depression. Acta Endocrinol 1991; 124:166-172
7. Whybrow PC: Behavior and psychiatric aspects of hypothyroidism, in Wegner and Ingbar's The Thyroid: A Fundamental and Clinical Text. Edited by Braverman LE, Utiger RD. Philadelphia, JB Lippincott, 1991, pp 1078-1083
8. Stancer HC, Persad E: Treatment of intractable rapid-cycling manic-depressive disorder with levothyroxine. Arch Gen Psychiatry 1982; 39:311-312
9. Bauer MS, Whybrow PC: The effect of changing thyroid function on cyclic affective illness in a human subject. Am J Psychiatry 1986; 143:633-636
10. Bauer MS, Whybrow PC: Rapid cycling bipolar disorder: clinical features, treatment, and etiology, in Advances in Neuropsychiatry and Psychopharmacology, vol 2: Refractory Depression. Edited by Amsterdam JD. New York, Raven Press, 1991, pp 191-208
11. Klein I: Metabolic, physiologic, and clinical indices of thyroid function, in Wegner and Ingbar's The Thyroid: A Fundamental and Clinical Text. Edited by Braverman LE, Utiger RD. Philadelphia, JB Lippincott, 1991, pp 486-492
12. Himwich HE, Daly C, Fazekas JF, Herrlich HC: Effect of thyroid medication on brain metabolism of cretins. Am J Psychiatry 1942; 98:489-493
13. Kety SS: Circulation and metabolism of the human brain in health and disease. Am J Med 1950; 8:205-217
14. 2 consumption to the total body metabolism in hyperthyroidism (abstract). J Clin Invest 1950; 29:847
15. Scheinberg P: Cerebral circulation and metabolism in hyperthyroidism. J Clin Invest 1950; 29:1010-1013
16. Sensenbach W, Madison L, Eisenberg S, Ochs L: The cerebral circulation and metabolism in hyperthyroidism and myxedema. J Clin Invest 1954; 33:1434-1440
17. Sokoloff L, Wechsler RL, Mangold R, Balls K, Kety SS: Cerebral blood flow and oxygen consumption in hyperthyroidism before and after treatment. J Clin Invest 1953; 32:202-208
18. Madison L, Sensenbach W, Ochs L: Effect of hyperthyroidism and myxedema upon cerebral blood flow and metabolism (abstract). Am J Med 1951; 11:246
19. Scheinberg P, Stead EAJ, Brannon ES, Warren JV: Correlative observation on cerebral metabolism and cardiac output in myxedema. J Clin Invest 1950; 29:1139-1146
20. O'Brien MD, Harris PH: Cerebral-cortex perfusion-rates in myxoedema. Lancet 1968; 1:1170-1172
21. 33p magnetic-resonance spectroscopy. Lancet 1995; 345:619-620
22. Endicott J, Spitzer RL: Use of the Research Diagnostic Criteria and the Schedule for Affective Disorders and Schizophrenia to study affective disorders. Am J Psychiatry 1979; 136:52-56
23. Post RM, Roy-Byrne PP, Uhde TW: Graphic representation of the life course of illness in patients with affective disorder. Am J Psychiatry 1988; 145:844-848
24. Bunney WE Jr, Hamburg DA: Methods for reliable longitudinal observation of behavior. Arch Gen Psychiatry 1963; 9:280-294
25. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62
26. Koeppe RA, Holden JE, Ip WR: Performance comparison of parameter estimation techniques for the quantitation of local cerebral blood flow by dynamic positron computed tomography. J Cereb Blood Flow Metab 1985; 5:224-234
27. Cohen RM, Semple WE, Gross M, Holcomb HH, Dowling MS, Nordahl TE: Functional localization of sustained attention: comparison to sensory stimulation in the absence of instruction. Neuropsychiatry, Neuropsychology, and Behavioral Neurology 1988; 1:3-20
28. Sokoloff L, Reivich M, Kennedy C, Rosiers MH, Patlak CS, Pettigrew KD, Sakurada O, Shinohara M: The [14C]deoxyglucose method for measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 1977; 28:897-916
29. Brooks RA, DiChiro G, Zukerburg BW, Bairamain D, Larson SM: Test-retest studies of cerebral glucose metabolism using fluorine-18 deoxyglucose: validation of method. J Nucl Med 1987; 28:53-59
30. Mazziotta JC, Phelps ME: Positron emission tomography studies of the brain, in Positron Emission Tomography and Autoradiography: Principles and Applications for the Brain and Heart. Edited by Phelps ME, Mazziotta JC, Schelbert H. New York, Raven Press, 1986, pp 493-579
31. Jones SC, Alavi A, Christman D, Montanez I, Wolf AP, Reivich M: The radiation dosimetry of 2-[F-18]fluoro-2-deoxy-D-glucose in man. J Nucl Med 1982; 23:613-617
32. ANALYZE: Reference Manual, version 5.0. Rochester, Minn, Mayo Foundation, Biomedical Imaging Resource, 1991
33. Friston KJ, Passingham RE, Nutt JG, Heather JD, Sawle GV, Frackowiak RSJ: Localisation in PET images: direct fitting of the intercommissural (AC-PC) line. J Cereb Blood Flow Metab 1989; 9:690-695
34. Talairach J, Tournoux P: Co-Planar Stereotaxic Atlas of the Human Brain. New York, Thieme Medical, 1988
35. Horwitz B, Maisog J, Kirschner P, Mentis M, Friston K, McIntosh AR: A computerized system for determining pixel-by-pixel correlations of functional activity measured by positron emission tomography. Soc Neurosci Abstracts 1993; 19:1604
36. Horwitz B: Data analysis paradigms for metabolic-flow data: combining neuromodelling and functional neuroimaging. Human Brain Mapping 1994; 2:112-122
37. Bench CJ, Friston KJ, Brown RG, Scott LC, Frackowiak RSJ, Dolan RJ: The anatomy of melancholia - focal abnormalities of cerebral blood flow in major depression. Psychol Med 1992; 22:607-615
38. Dolan RJ, Bench CJ, Brown RG, Scott LC, Friston KJ, Frackowiak RSJ: Regional cerebral blood flow abnormalities in depressed patients with cognitive impairment. J Neurol Neurosurg Psychiatry 1992; 55:768-773
39. Kerter TA, Andreason PJ, George MS, Marangell LB, Pazzaglia PJ, Post RM: Reduced resting frontal lobe cerebral blood flow in mood disorders, in New Research Program and Abstracts, 146th Annual Meeting of the American Psychiatric Association. Washington, DC, APA, 1993, p. 135
40. Baxter LR, Schwartz JM, Phelps ME, Mazziotta JC, Guze BH, Selin CE, Gerner RH, Sumida RM: Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry 1989; 46:243-250
41. Buchsbaum MS, Delisi LE, Holcomb HH, Cappelletti J, King AC, Johnson J, Hazlett E: Anteroposterior gradients in cerebral glucose use in schizophrenia and affective disorders. Arch Gen Psychiatry 1984; 41:1159-1166
42. Buchsbaum MS, Wu J, Delisi LE, Holcomb H, Kessler R, Johnson J, King AC, Hazlett E, Langston K, Post RM: Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness. J Affect Disord 1986; 10:137-152
43. Schwartz JM, Baxter LR, Mazziotta JC, Gerner RH, Phelps ME: The differential diagnosis of depression: relevance of positron emission tomography studies of cerebral glucose metabolism to the bipolar-unipolar dichotomy. JAMA 1987; 258:1368-1374
44. Mayberg HS, Starkstein SE, Peyser CE, Folstein SE, Dannals RF, Brandt J: Paralimbic frontal lobe hypometabolism in depression associated with Huntington's disease. Neurology 1992; 42:1791-1797
45. Cohen RM, Gross M, Nordahl TE, Semple WE, Oren DA, Rosenthal N: Preliminary data on metabolic brain pattern of patients with winter seasonal affective disorder. Arch Gen Psychiatry 1992; 49:545-552
46. Cohen RM, Semple WE, Gross M, King AC, Nordahl TE: Metabolic brain pattern of sustained auditory discrimination. Exp Brain Res 1992; 92:165-172
47. Andreasen NC, O'Leary DS, Cizadlo T, Arndt S, Rezai K, Watkins GL, Boles Ponto LL, Hichwa RD: Remembering the past: two facets of episodic memory explored with positron emission tomography. Am J Psychiatry 1995; 152:1576-1585
48. Baumgartner A, Graf KJ, Kurten I, Meinhold H: Thyrotropin (TSH) and thyroid hormone concentrations during partial sleep deprivation in patients with major depressive disorder. J Psychiatr Res 1990; 24:281-292
49. Baumgartner A, Riemann D, Berger M: Neuroendocrinological investigations during sleep deprivation in depression, II: longitudinal measurement of thyrotropin, TH, cortisol, prolactin, GH, and LH during sleep and sleep deprivation. Biol Psychiatry 1990; 28:569-587
50. Baumgartner A, Graf K-J, Kurten I, Meinhold H, Scholz P: Neuroendocrinological investigations during sleep deprivation in depression, I: early morning levels of thyrotropin, TH, cortisol, prolactin, LH, FSH, estradiol, and testosterone. Biol Psychiatry 1990; 28:556-568
51. Kasper S, Sack DA, Wehr TA, Kick H, Voll G, Vieira A: Nocturnal TSH and prolactin secretion during sleep deprivation and prediction of antidepressant response in patients with major depression. Biol Psychiatry 1988; 24:631-641
52. Wu JC, Gillin JC, Buchsbaum MS, Hershey T, Johnson JC, Bunney WE Jr: Effect of sleep deprivation on brain metabolism of depressed patients. Am J Psychiatry 1992; 149:538-543